Congress Wealth Management LLC DE reduced its stake in shares of AdvanSix Inc. (NYSE:ASIX – Free Report) by 69.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,673 shares of the company’s stock after selling 30,982 shares during the period. Congress Wealth Management LLC DE’s holdings in AdvanSix were worth $390,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of ASIX. AlphaQuest LLC purchased a new stake in AdvanSix during the fourth quarter valued at about $94,000. Quantbot Technologies LP lifted its stake in shares of AdvanSix by 618.5% during the 3rd quarter. Quantbot Technologies LP now owns 4,361 shares of the company’s stock valued at $132,000 after buying an additional 3,754 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in AdvanSix in the 4th quarter worth approximately $137,000. Public Employees Retirement System of Ohio grew its stake in AdvanSix by 29.9% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 6,067 shares of the company’s stock valued at $184,000 after buying an additional 1,396 shares in the last quarter. Finally, Quadrature Capital Ltd bought a new stake in AdvanSix during the 3rd quarter valued at $204,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.
Insider Activity
In other news, CEO Erin N. Kane sold 5,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $30.19, for a total transaction of $150,950.00. Following the transaction, the chief executive officer now directly owns 502,795 shares in the company, valued at approximately $15,179,381.05. This represents a 0.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.60% of the company’s stock.
AdvanSix Price Performance
AdvanSix (NYSE:ASIX – Get Free Report) last issued its quarterly earnings data on Friday, February 21st. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.37) by $0.40. The company had revenue of $329.06 million during the quarter, compared to analyst estimates of $377.15 million. AdvanSix had a return on equity of 6.26% and a net margin of 2.91%. On average, research analysts expect that AdvanSix Inc. will post 4 EPS for the current fiscal year.
AdvanSix Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, March 24th. Stockholders of record on Monday, March 10th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.84%. The ex-dividend date was Monday, March 10th. AdvanSix’s payout ratio is 39.75%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on ASIX shares. UBS Group set a $35.00 price target on AdvanSix in a research report on Tuesday, March 18th. Piper Sandler decreased their price target on AdvanSix from $39.00 to $35.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 18th. Finally, StockNews.com lowered shares of AdvanSix from a “buy” rating to a “hold” rating in a research report on Monday, March 24th.
View Our Latest Analysis on AdvanSix
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
Featured Stories
- Five stocks we like better than AdvanSix
- Where Do I Find 52-Week Highs and Lows?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Stock Average Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding ASIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdvanSix Inc. (NYSE:ASIX – Free Report).
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.